Pilot study of irinotecan/oxalipltin (IROX) combination chemotherapy for patients with gemcitabine- and 5-fluorouracil- refractory pancreatic cancer
2009 ◽
Vol 28
(3)
◽
pp. 343-349
◽
Keyword(s):
Keyword(s):
Keyword(s):
2010 ◽
Vol 84
(4)
◽
pp. 310-315
◽
2017 ◽
Vol 10
(6)
◽
pp. 551-557
◽